Late Phase Study Trends and Market Outlook (2016-2020)

Report Overview

In much of our research, we make a point to ask respondents for their outlook on market changes or trends they expect to occur regarding a specific topic. Keeping an eye on what is coming down the pike is critical to ensure the industry isn’t moving forward without you. No one wants to be left in the dust…which can happen quickly in the ever-changing pharmaceutical industry.  To this end, ISR dedicated a research effort to providing a broad view into the industry’s perspectives on the clinical development market.  For this report, 102 Late Phase decision-makers were surveyed to gather their insights into where the Late Phase market is expected to head over the next four years.

What you will learn:

• 4-year examination of the industry’s Late Phase market dynamics, such as study volume and outsourced spend, analyzed by study design (Interventional studies and Observational research) and by study type (Post-marketing Safety studies, Health Economics and Outcomes Research, and Expanded Access studies)
• Average dollar value of outsourced Late Phase studies and how this varies by sponsor size
• Criteria sponsors use to select (and disqualify) clinical service providers
• Current and future predictions for Late Phase trends, including use of technology, study complexity, and reliance on EMRs

How you can use this report:

• Gain understanding of the key decision-makers within sponsor organizations to develop more targeted communications
• Learn the most desirable characteristics of a Late Phase
  service provider
• Discover trends in Late Phase technology use